9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium

Author： Kindler Hedy   Avadhani Anjali   Wade-Oliver Kurombi   Karrison Theodore   Mani Sridhar   Vokes Everett  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.22, Iss.3, 2004-08, pp. : 323-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

By Nimeiri Halla   Singh Deepti   Kasza Kristen   Taber David   Ansari Rafat   Vokes Everett   Kindler Hedy  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 854-858

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction

By Adelstein David  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1684-1689

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia

By Gomez-Abuin Gonzalo   Winquist Eric   Stadler Walter   Pond Greg   Degendorfer Pamela   Wright John   Moore Malcolm  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 181-185

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

By Whitehead Robert   Benedetti Jacqueline   Abbruzzese James   Ardalan Bach   Goodwin J.   Balcerzak Stanley   Samlowski Wolfram   Lenz Heinz-Josef   Macdonald John  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

By Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 353-357

Springer Publishing Company

Access to resources Recommend Favorite